Kimberly Kelly, PhD, the CEO of a biotech startup called ZielBio, received an AACR-PanCAN Career Development Award for Pancreatic Cancer Research as one of the first grants of her independent academic career. The value of the grant, she says, is more than the money.
The AACR NextGen Grants for Transformative Cancer Research represent the AACR’s flagship funding initiative to stimulate highly innovative research from young investigators. 2017 NextGen grantee, Hani Goodarzi, PhD, shares the impact of this grant on his career and on metastasis research, especially in colorectal cancer.
When Edna Cukierman, PhD, obtained an independent research position and decided to apply for a cancer research grant, she had one problem: “I didn’t know anything about cancer,” she recalls.
The AACR-Novocure Tumor Treating Fields Research Grants represent a joint effort to promote and support innovative research focused on Tumor Treating Fields (TTFields), which are intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells. 2020 grant recipient Carsten Hagemann, PhD, shares his perspectives on the myriad benefits of the grant.
After undergraduate education at Harvard University, Ravi Majeti earned his MD and PhD at University of California San Francisco. He took an interest in acute myeloid leukemia (AML) in medical school and cared for patients with AML during his residency in internal medicine at Brigham and Women’s Hospital in Boston and Hematology fellowship at Stanford University...
Dr. Channing Der serves as the Sarah Graham Kenan Professor of Pharmacology at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill. Having received his PhD from the University of California at Irvine, Dr. Der went on to complete his postdoctoral research training at the Dana-Farber Cancer Institute and Harvard Medical School. As a two-time PanCAN-AACR grant recipient...
For Michael Jensen, MD, a grant from the AACR came at a good time. It was 1996, and Jensen was at the Fred Hutchinson Cancer Research Center in Seattle for his fellowship as a pediatric oncologist-hematologist, working in the laboratory of....
Dr. Sonia del Rincón and the Stand Up to Cancer (SU2C) Canada Metastatic Breast Cancer Dream Team are looking to understand the impact of MAP kinase–interacting serine/threonine kinases 1 and 2 (MNK1/2) inhibitors on metastatic breast cancer...